Backers of an effort to legalize and regulate recreational marijuana use in Washington state submitted more than 340,000 signatures Thursday to try to qualify their initiative, a move protested by some legalization supporters who say the proposal would hurt medical-marijuana patients. About a dozen protesters carried signs that read "Legalize, not penalize," and shouted as members of New Approach turned in signatures for Initiative 502 to the Legislature.
The Hungarian Civil Liberties Union (HCLU) traveled to California and attended the International Drug Policy Reform Conference in LA to find out what are the latest development of the battle for legal marijuana in the US. We interviewed activists from several organizations, asked questions about the chances of state level ballot initiatives, we even saw how people will use cannabis in the 21st Century. Welcome to the future of US marijuana regulation - please watch and share HCLU's new movie.
Health officials of the Basque Country, an autonomous region of Spain, announced that they will introduce a bill to regulate the "cultivation, sale and consumption" of hashish and marijuana. The bill, which will be presented to the regional parliament next year, was put forward on December 12, 2011, by regional health officials during the presentation of the regional addictions plan. Several media outlets broke the news as an intent to legalise cannabis use, while in fact the proposed legislation only aims to regulate cannabis user associations that cultivate for personal use.
The Basque Parliament will approve a law bill in the first few months of 2012 on drug addiction, which will regulate "the growing, sale and consumption of cannabis". For the new ruling, for which "technical and legal studies have been undertaken", the regional government wants to "open a debate" with associations in favour of consumption and to "shape their rights".
Imagine an extremely expensive government policy proven to be completely ineffective at achieving its stated objectives. Consider also that whenever this policy is subjected to any kind of impact assessment, the government’s own data clearly show that the policy has been ineffective, expensive and fuelled the growth of organized crime. Finally, imagine this remarkable set of circumstances persisting for decades — at great cost to taxpayers and community safety — and yet elected officials say and do nothing to address the status quo.
A committee has now been established to determine the best way to legalise the sale of hashish, with special stores owned by the council presenting itself as the preferred candidate. The sale, consumption and cultivation of marijuana is illegal in Denmark, all of which can be punished with warnings, fines or jail time. Despite this there is a strong black market for the drug generating 1.5 billion kroner a year and controlled entirely by criminal gangs.
The former head of MI5 believes the "war on drugs" has proved fruitless and it is time to consider decriminalising the possession and use of small quantities of cannabis. Eliza Manningham-Buller has backed calls for the government to set up a commission to examine how to tackle the UK's drug culture and consider the highly controversial move of relaxing the law. She was speaking at a meeting held by the All Party Parliamentary Group on Drug Policy Reform.
Marijuana legalization in Washington has been an activist's pipe dream for decades, but a new campaign with deep pockets and prominent supporters is poised to force the state Legislature to vote on the issue or send it to the 2012 presidential ballot.The group, New Approach Washington, is the strongest mainstream campaign to date, since former federal prosecutor John McKay backed the campaign.
The California Medical Association made news when it became the first state medical association to recommend the legalization and regulation of cannabis. The CMA's Council on Scientific and Clinical Affairs noted in its recommendations that there is an increasing body of evidence that marijuana may be useful in the treatment of a number of medical conditions, but research to determine both risks and benefits is hampered in the United States because marijuana still is classified as an illegal drug.
In 1976 the Netherlands adopted a formal written policy of non-enforcement for violations involving possession or sale of up to 30 g of cannabis. The ‘gateway theory’ has long been seen as an argument for being tough on cannabis, but interestingly, the Dutch saw that concept as a rationale for allowing retail outlets to sell small quantities. Rather than seeing an inexorable psychopharmacological link between marijuana and hard drugs, the Dutch hypothesized that the gateway mechanism reflected social and economic networks, so that separating the markets would keep cannabis users out of contact with hard-drug users and sellers.
A grey area has emerged between what is legal and what is not as states struggle with how to respond to the many new synthetic compounds emerging onto the market. Of the various types of ‘Legal highs’ the seminar focused on stimulants because of the parallels with the other main drug-policy issue of the moment; i.e. the status of traditional herbal stimulants. These older discussions have been reinvigorated by: Bolivia’s efforts to de-schedule coca-leaf at UN level; the debates on the status of khat between EU States, and of kratom across Asia; and the increasing stride of legitimate cannabis use on the domestic front, as in for example Spain.
This paper aims to set out some of the policy and public health issues raised by the appearance of a wide range of emergent psychoactive substances of diverse origin, effect and risk profile (commonly referred to as ‘legal highs’). It will start by considering what is meant by the term ‘legal highs’ and consider the historical context that has framed their appearance and must inform any response. It will then consider some of the approaches that have been adopted by different nations to control their availability and associated harms, including a preliminary assessment of their consequences, both intended and not.
This brief report outlines the links between cannabis prohibition in British Columbia (Canada) and the growth of organized crime and related violence in the province, and is the first report of a coalition of concerned citizens and experts known as Stop the Violence BC. The report also defines the public health concept “regulation” and seeks to set the stage for a much needed public conversation and action on the part of BC politicians.
Benedikt Fischer, Victoria Jeffries, Wayne Hall, Robin Room, Elliot Goldner, Jürgen Rehm
01 September 2011
More than one in ten adults – and about one in three young adults – report past year cannabis use in Canada. While cannabis use is associated with a variety of health risks, current policy prohibits all use, rather than adopting a public health approach focusing on interventions to address specific risks and harms as do policies for alcohol. The objective of this paper was to develop ‘Lower Risk Cannabis Use Guidelines’ (LRCUG) based on research evidence on the adverse health effects of cannabis and factors that appear to modify the risk of these harms.
University of Paris economist Pierre Kopp wants to legalize marijuana for entirely economic reasons. Kopp tells Le Monde [translated]: "For economists, the public good is that which minimizes the cost to society, in other words those which permit the improvement of public well-being at the least cost."
Marijuana laws should be set at the state, not federal, level, Reps. Ron Paul and Barney Frank argued in a bill they introduced Thursday. The goal of the bill, HR 2306 or the Ending Federal Marijuana Prohibition Act of 2011, is not to legalize marijuana but to remove it from the list of federally controlled substances while allowing states to decide how they will regulate it.
The global war on drugs has failed, with devastating consequences for individuals and societies around the world. Fifty years after the initiation of the UN Single Convention on Narcotic Drugs, and 40 years after President Nixon launched the US government’s war on drugs, fundamental reforms in national and global drug control policies are urgently needed.
Since first coming to public prominence at the end of 2009, legal highs have posed a major challenge to existing legal and legislative structures designed to deal with drugs. With the market in manufactured psychoactive substances like mephedrone moving faster than public policy can accommodate, this report asks whether the assumptions enshrined in the 40-year-old Misuse of Drugs Act (MDA) are still valid when applied 21st century drugs market.
The New Zealand Law Commission was asked to address the efficacy of the Misuse of Drugs Act in reducing the demand for, and supply of, drugs prohibited under the International Drug Conventions. The Commission has recommended the existing Act be repealed and replaced by a new Act administered by the Ministry of Health. Justice Hammond said the thrust of the proposed new Act is to facilitate a more effective interface between the criminal justice and health sectors: “We need to recognise that the abuse of drugs is both a health and a criminal public policy problem.”